Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.60 |
| ▸ | CTSK | P43235 | 1/20 | 0.60 |
| ▸ | PAM | P19021 | 1/20 | 0.60 |
| ▸ | CTRB1 | P17538 | 4/20 | 0.55 |
| ▸ | TACR1 | P25103 | 1/20 | 0.55 |
| ▸ | GNPAT | O15228 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | ACE | P12821 | 1/20 | 0.51 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | MMP7 | P09237 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20079849 | 1.00 | CTSS (0.60) | CTSSCTSKPAMCTRB1TACR1 | |
| SCHEMBL8534420 | 0.87 | PSMB5 (0.58) | CTSSACEMMP1MMP2MMP3 | |
| SCHEMBL8533429 | 0.87 | PSMB5 (0.58) | CTSSACEMMP1MMP2MMP3 | |
| SCHEMBL25827981 | 0.85 | GRIA1 (0.51) | CTSSCTSKPAMTACR1ACE | |
| SCHEMBL21399308 | 0.85 | POLB (0.54) | SMN1; SMN2ACEMMP1MMP2MMP3 | |
| SCHEMBL14865867 | 0.85 | CTSG (0.62) | CTSSCTSKPAMCTRB1TACR1 | |
| SCHEMBL14363442 | 0.85 | CTSG (0.62) | CTSSCTSKPAMCTRB1TACR1 | |
| SCHEMBL18506593 | 0.84 | CTSC (0.56) | ACEMMP1MMP2MMP3MMP7 | |
| SCHEMBL11168240 | 0.84 | CTSS (0.55) | CTSSCTSKPAMCTRB1TACR1 | |
| Afalanine SCHEMBL158612 | 0.84 | CTSS (0.65) | CTSSCTSKPAMCTRB1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130096317-A1 | REDUCTION OF ALDEHYDES AND KETONES TO ALCOHOLS | GEORGIA TECH RESEARCH CORPORATION (US) | 2013-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130096317-A1 | REDUCTION OF ALDEHYDES AND KETONES TO ALCOHOLS | POF1B, PHF2, ADH1C | CTSS 4614/4885CTSK 4698/4885PAM 1218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.